Kamaraj Karunanithi

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Multiple Myeloma

Gas Chromatography

Histone Deacetylase

Top Venues

Antibodies (Basel, Switzerland)

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Hannah V Giles, Kamaraj Karunanithi
Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies. Antibodies (Basel, Switzerland) 13 (1) (2024)
Hannah V Giles, Kamaraj Karunanithi
Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies. Antibodies (Basel, Switzerland) 13 (1) (2024)
Hannah V Giles, Kamaraj Karunanithi
Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies. Antibodies (Basel, Switzerland) 13 (1) (2024)
Hannah V Giles, Kamaraj Karunanithi
Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies. Antibodies (Basel, Switzerland) 13 (1) (2024)
Stella Bowcock, Catherine Atkin, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Richard D Neal, Tim Planche, Kamaraj Karunanithi, Stephen Jenkins, Simon Stern, Sarah Arnott, Peter Toth, Farooq A Wandroo, Janet A Dunn, Mark T Drayson, null null
Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial. Cancers 15 (13) (2023)
Matthew W Jenner, Charlotte Pawlyn, Faith E Davies, Tom Menzies, Anna Hockaday, Catherine Olivier, John R Jones, Kamaraj Karunanithi, Jindriska Lindsay, Bhuvan Kishore, Curly T C M Morris, Mark T Drayson, Martin F Kaiser, Roger G Owen, Walter Gregory, David A Cairns, Gareth J Morgan, Graham H Jackson, null null
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial. British journal of haematology (2022)
Graham H Jackson, Charlotte Pawlyn, David A Cairns, Ruth M de Tute, Anna Hockaday, Corinne Collett, John R Jones, Bhuvan Kishore, Mamta Garg, Cathy D Williams, Kamaraj Karunanithi, Jindriska Lindsay, Alberto Rocci, John A Snowden, Matthew W Jenner, Gordon Cook, Nigel H Russell, Mark T Drayson, Walter Martin Gregory, Martin F Kaiser, Roger G Owen, Faith E Davies, Gareth J Morgan, null null
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial. PLoS medicine 18 (1) (2021)
James Croft, Sidra Ellis, Amy L Sherborne, Kim Sharp, Amy Price, Matthew W Jenner, Mark T Drayson, Roger G Owen, Sally Chown, Jindriska Lindsay, Kamaraj Karunanithi, Hannah Hunter, Walter Martin Gregory, Faith E Davies, Gareth J Morgan, Curly T C M Morris, Lilit Atanesyan, Suvi Savola, David A Cairns, Graham Jackson, Richard S Houlston, Martin F Kaiser
Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial. Leukemia 35 (7) (2020)